This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An author's correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chevalier, M. S.
Right arrow Articles by Johnson, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chevalier, M. S.
Right arrow Articles by Johnson, D. C.

 Previous Article  |  Next Article 

Journal of Virology, August 2002, p. 8265-8275, Vol. 76, No. 16
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.16.8265-8275.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Binding of Human Cytomegalovirus US2 to Major Histocompatibility Complex Class I and II Proteins Is Not Sufficient for Their Degradation

Mathieu S. Chevalier, Gwynn M. Daniels, and David C. Johnson*

Department of Molecular Microbiology and Immunology, Oregon Health Sciences University, Portland, Oregon 97201

Received 19 March 2002/ Accepted 15 May 2002

Human cytomegalovirus (HCMV) glycoprotein US2 causes degradation of major histocompatibility complex (MHC) class I heavy-chain (HC), class II DR-{alpha} and DM-{alpha} proteins, and HFE, a nonclassical MHC protein. In US2-expressing cells, MHC proteins present in the endoplasmic reticulum (ER) are degraded by cytosolic proteasomes. It appears that US2 binding triggers a normal cellular pathway by which misfolded or aberrant proteins are translocated from the ER to cytoplasmic proteasomes. To better understand how US2 binds MHC proteins and causes their degradation, we constructed a panel of US2 mutants. Mutants truncated from the N terminus as far as residue 40 or from the C terminus to amino acid 140 could bind to class I and class II proteins. Nevertheless, mutants lacking just the cytosolic tail (residues 187 to 199) were unable to cause degradation of both class I and II proteins. Chimeric proteins were constructed in which US2 sequences were replaced with homologous sequences from US3, an HCMV glycoprotein that can also bind to class I and II proteins. One of these US2/US3 chimeras bound to class II but not to class I, and a second bound class I HC better than wild-type US2. Therefore, US2 residues involved in the binding to MHC class I differ subtly from those involved in binding to class II proteins. Moreover, our results demonstrate that the binding of US2 to class I and II proteins is not sufficient to cause degradation of MHC proteins. The cytosolic tail of US2 and certain US2 lumenal sequences, which are not involved in binding to MHC proteins, are required for degradation. Our results are consistent with the hypothesis that US2 couples MHC proteins to components of the ER degradation pathway, enormously increasing the rate of degradation of MHC proteins.

* Corresponding author. Mailing address: Mail code L-220, Department of Molecular Microbiology and Immunology, Oregon Health Sciences University, Portland, OR 97201. Phone: (503) 494-0834. Fax: (503) 494-6862. E-mail: johnsoda{at}ohsu.edu.

Journal of Virology, August 2002, p. 8265-8275, Vol. 76, No. 16
0022-538X/02/$04.00+0     DOI: 10.1128/JVI.76.16.8265-8275.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Noriega, V. M., Tortorella, D. (2008). A Bipartite Trigger for Dislocation Directs the Proteasomal Degradation of an Endoplasmic Reticulum Membrane Glycoprotein. J. Biol. Chem. 283: 4031-4043 [Abstract] [Full Text]  
  • Wiertz, E. J., Devlin, R., Collins, H. L., Ressing, M. E. (2007). Herpesvirus Interference with Major Histocompatibility Complex Class II-Restricted T-Cell Activation. J. Virol. 81: 4389-4396 [Full Text]  
  • Hegde, N. R., Chevalier, M. S., Wisner, T. W., Denton, M. C., Shire, K., Frappier, L., Johnson, D. C. (2006). The Role of BiP in Endoplasmic Reticulum-associated Degradation of Major Histocompatibility Complex Class I Heavy Chain Induced by Cytomegalovirus Proteins. J. Biol. Chem. 281: 20910-20919 [Abstract] [Full Text]  
  • Oresic, K., Noriega, V., Andrews, L., Tortorella, D. (2006). A Structural Determinant of Human Cytomegalovirus US2 Dictates the Down-regulation of Class I Major Histocompatibility Molecules. J. Biol. Chem. 281: 19395-19406 [Abstract] [Full Text]  
  • Lu, X., Kavanagh, D. G., Hill, A. B. (2006). Cellular and Molecular Requirements for Association of the Murine Cytomegalovirus Protein m4/gp34 with Major Histocompatibility Complex Class I Molecules.. J. Virol. 80: 6048-6055 [Abstract] [Full Text]  
  • Thilo, C., Berglund, P., Applequist, S. E., Yewdell, J. W., Ljunggren, H.-G., Achour, A. (2006). Dissection of the Interaction of the Human Cytomegalovirus-derived US2 Protein with Major Histocompatibility Complex Class I Molecules: PROMINENT ROLE OF A SINGLE ARGININE RESIDUE IN HUMAN LEUKOCYTE ANTIGEN-A2. J. Biol. Chem. 281: 8950-8957 [Abstract] [Full Text]  
  • Pande, N. T., Powers, C., Ahn, K., Fruh, K. (2005). Rhesus Cytomegalovirus Contains Functional Homologues of US2, US3, US6, and US11. J. Virol. 79: 5786-5798 [Abstract] [Full Text]  
  • Jenkins, C., Abendroth, A., Slobedman, B. (2004). A Novel Viral Transcript with Homology to Human Interleukin-10 Is Expressed during Latent Human Cytomegalovirus Infection. J. Virol. 78: 1440-1447 [Abstract] [Full Text]  
  • Barel, M. T., Ressing, M., Pizzato, N., van Leeuwen, D., Le Bouteiller, P., Lenfant, F., Wiertz, E. J. H. J. (2003). Human Cytomegalovirus-Encoded US2 Differentially Affects Surface Expression of MHC Class I Locus Products and Targets Membrane-Bound, but Not Soluble HLA-G1 for Degradation. J. Immunol. 171: 6757-6765 [Abstract] [Full Text]  
  • Petersen, J. L., Morris, C. R., Solheim, J. C. (2003). Virus Evasion of MHC Class I Molecule Presentation. J. Immunol. 171: 4473-4478 [Full Text]  
  • Hegde, N. R., Johnson, D. C. (2003). Human Cytomegalovirus US2 Causes Similar Effects on Both Major Histocompatibility Complex Class I and II Proteins in Epithelial and Glial Cells. J. Virol. 77: 9287-9294 [Abstract] [Full Text]  
  • Elkington, R., Walker, S., Crough, T., Menzies, M., Tellam, J., Bharadwaj, M., Khanna, R. (2003). Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers. J. Virol. 77: 5226-5240 [Abstract] [Full Text]  
  • Chevalier, M. S., Johnson, D. C. (2003). Human Cytomegalovirus US3 Chimeras Containing US2 Cytosolic Residues Acquire Major Histocompatibility Class I and II Protein Degradation Properties. J. Virol. 77: 4731-4738 [Abstract] [Full Text]  
  • Arieh, S. V.-B., Laham, N., Schechter, C., Yewdell, J. W., Coligan, J. E., Ehrlich, R. (2003). A single viral protein HCMV US2 affects antigen presentation and intracellular iron homeostasis by degradation of classical HLA class I and HFE molecules. Blood 101: 2858-2864 [Abstract] [Full Text]  
  • Collins, W. J., Johnson, D. C. (2003). Herpes Simplex Virus gE/gI Expressed in Epithelial Cells Interferes with Cell-to-Cell Spread. J. Virol. 77: 2686-2695 [Abstract] [Full Text]  
  • Hegde, N. R., Tomazin, R. A., Wisner, T. W., Dunn, C., Boname, J. M., Lewinsohn, D. M., Johnson, D. C. (2002). Inhibition of HLA-DR Assembly, Transport, and Loading by Human Cytomegalovirus Glycoprotein US3: a Novel Mechanism for Evading Major Histocompatibility Complex Class II Antigen Presentation. J. Virol. 76: 10929-10941 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»